Fig. 3 | Leukemia

Fig. 3

From: Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome

Fig. 3

Cumulative incidence of blast progression, AML evolution, and overall survival of h-MDS according to hg-score. a Cumulative incidence of blast progression, as defined by increase of BM blast percentage (to ≥ 5% for MDS without excess blasts, to a higher MDS-EB category or AML for MDS-EB) of patients with hypoplastic MDS according to the hg-score. Red curve refers to patients with low score (i.e., hg-score < 2), blue curve to high score (i.e., hg-score ≥ 2). b Cumulative incidence of AML progression of patients with hypoplastic MDS according to the hg-score (high hg-score: blue curve; low hg-score: red curve), n-MDS (black curve), and AA (green curve). c Overall Survival of patients with hypoplastic MDS according to the hg-score (high hg-score: blue curve; low hg-score: red curve), n-MDS (black curve) and AA (green curve)

Back to article page